American Society for Microbiology, Journal of Clinical Microbiology, 3(60), 2022
DOI: 10.1128/jcm.02169-21
Full text: Unavailable
Diagnosis of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) remains unclear especially in nonimmunocompromised patients. The aim of this study was to evaluate seven mycological criteria and their combination in a large homogenous cohort of patients.